SENSEX NIFTY

Breast Cancer

Apr 26, 2016 at 22:08 | Source: PTI
The Delhi High Court has allowed pharma firms, Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd, to continue with manufacture and marketing of their breast cancer drug under their brand names 'CANMAb' and 'HERTRAZ'.
Apr 26, 2016 at 20:00 | Source: PTI
Biotechnology firm Biocon today said its product portfolio will not be affected by an order of the Delhi High Court that prevented the company from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
Feb 08, 2016 at 08:53 | Source: PTI
The Mumbai-based company has included its two drugs -- Abirapro prescribed for prostate cancer and Evermil, indicated for different cancers, such as breast and renal cell carcinoma -- under the scheme. Currently, Abirapro 250 mg in 120 pack size is priced at Rs 39,990.
Dec 02, 2015 at 10:35 | Source: Moneycontrol.com
The disease burden of breast cancer is quite high.
Oct 12, 2015 at 19:41 | Source: PTI
These targeted medicines represent a completely new way to treat HER2-positive metastatic breast cancer, with which the company aims to help women in India live as long and as well as possible, he added.
Sep 15, 2015 at 16:45 | Source: PTI
GBR 1302, a bi-specific monoclonal antibody, is an artificial protein that is composed of fragments of two different monoclonal antibodies and consequently binds two different types of antigens.
Aug 19, 2015 at 17:36 | Source: PTI
These tests will help screen for cancer risks and enable families of cancer patients to take various preventive measures. All testing will be carried out at Myriad's labs in USA and Germany, the companies said in a statement.
Oct 20, 2014 at 18:41 | Source: Moneycontrol.com
Watch out for the dense breast tissue
Oct 20, 2014 at 18:39 | Source: Moneycontrol.com
What India thinks about breast cancer
Oct 20, 2014 at 18:37 | Source: Moneycontrol.com
Breast cancer: Let the pink revolution begin!
Messages on Breast Cancer »

Khushi1979

New Member

0 Follower

GAIL  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

10.55 AM Jan 19th

k.v.renga

Platinum Member

1377 Followers

Biocon  

Source:----BS:----) Strong growth prospects: In Biocon, investors see a blockbuster pipeline US nod to application for breast cancer drug is latest positive for the stock Ujjval Jauhari | New Delhi January 18, 2017 Last Updated at 10:53 IST

9.48 PM Jan 18th

BSE/NSE Announcer

Platinum Member

20393 Followers

Cadila Health  

Zydus Cadila has received the final approval from the USFDA to market Methotrexate tablets USP, 2.5 mg, a chemotherapy drug used for leukemias, lymphomas, breast cancer, lung cancer, and head and neck cancer and other cancers.

3.16 PM Jan 18th

stock specific

Platinum Member

219 Followers

Biocon  

USFDA to review Biocon-Mylan`s biosimilar drug for breast cancer news may give the push for the biocon share price to 1025 Read more at:

11.56 PM Jan 11th

N2O

Platinum Member

211 Followers

Biocon  

Hopefully Biocon-Mylan will get USFDA approval for biosimilars for breast cancer

9.17 PM Jan 11th

Wire News

Platinum Member

694 Followers

News Now  

Leading photography and imaging company Fujifilm today announced a tie-up with Sri Ramachandra University here to install a breast cancer diagnostic machine at the varisty.

5.42 PM Oct 22nd 2016

satya2802

New Member

0 Follower

Pfizer  

now pfizer had got some superb cancer drugs for breast cancer & prostet cancer that to all are printed drugs, any day it became a multi bigger stock keep watching

11.13 AM Sep 30th 2016

Web Messenger

Platinum Member

369230 Followers

Health & Grooming  

Source:DNA India - Delaying childbirth by 15 years after menarche may lower the odds of an aggressive form of breast cancer by 60%, says a new study. We found that the interval between menarche and age at first live birth is inversely associated with the risk of triple-negative breast cancer, said

1.36 PM Dec 14th 2012

Wire News

Platinum Member

694 Followers

News Now  

Karisma Kapoor supporting breast cancer cause

1.00 PM Dec 14th 2012

Web Messenger

Platinum Member

369230 Followers

Cipla  

Source:Business Standard - Drugmaker Cipla cut prices of three cancer drugs between 50% and 64% with immediate effect, after it announced similar price cuts for three drugs early this year. Lung cancer drug Erlocip would cost Rs 9,900 for 30 tablets instead of Rs 27,000 earlier, while breast cancer

8.44 PM Nov 8th 2012

News across the web »
Jan 04, 2017 at 15:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.